Share This Article:

Management of a patient on dual antiplatelet therapy presented for living donor liver transplant

Abstract Full-Text HTML XML Download Download as PDF (Size:86KB) PP. 115-118
DOI: 10.4236/crcm.2013.22030    2,939 Downloads   4,310 Views  

ABSTRACT

We report a case of a patient who underwent Living Donor Liver Transplantation (LDLT) while being continued on his dual antiplatelet regimen of clopidigrel and aspirin perioperatively. The patient had two drug eluting stents for coronary artery disease placed eight months prior to surgery. Preoperative thromboelastography and platelet mapping showed normal clot formation. Based on these tests it was determined that preoperative platelet transfusion was not necessary. The surgery proceeded relatively uneventfully. The patient received 1 unit of packed red blood cells intraoperatively and continued on aspirin during the postoperative period with no evidence of bleeding or cardiac ischemia.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

Moguilevitch, M. , Delphin, E. , Widyn, J. and Turk, D. (2013) Management of a patient on dual antiplatelet therapy presented for living donor liver transplant. Case Reports in Clinical Medicine, 2, 115-118. doi: 10.4236/crcm.2013.22030.

References

[1] Emond, J.C., Whitington, P.F., Thistlewaite, J.R., Alonso, E.M. and Broelsch, C.E. (1989) Reduced-size orthotopic liver transplantation: Use in the management of children with chronic liver disease. Hepatology, 10, 867-872. doi:10.1002/hep.1840100520
[2] Broelsch, C.E., Burdelski, M.D., Rogiers, X., Gundlach, M., Knoefel, W.T., Langwieler, T., Fischer, L. and Latta, A. (1994) Living donor for liver transplantation. Hepatology, 20, 49S-55S.
[3] Nadalin, S., Bockhorn, M., Malago, M., Valentin-Gamazo, C., Frilling, A. and Broelsch, C.E. (2006) Living donor liver transplantation. Hepato-Pancreato-Biliary Association, 1, 10-21.
[4] Lentine, K.L., Costa, S.P. and Weir, M.R. (2012) Cardiac disease evaluation and management among kidney and liver transplant candidates. A scientific statement from AHA/ACCF. Journal of American College of Cardiology, 60, 434-480. doi:10.1016/j.jacc.2012.05.008
[5] Levine, G.N., Bates, E.R., Blankenship, J.C., Bailey, S.R., Bittl, J.A., Cercek, B. and Chambers, C.E. (2011) ACCF/ AHA/SCAI Practice Guideline for Percutaneous Coronary Intervention Executive summary. Circulation, 124, 2574-2609.
[6] A report by American Society of Anesthesiologists Committee on Standards and Practice Parameters (2009) Practice alert for perioperative management of patients with coronary artery stents. Anesthesiology, 110, 22-23.
[7] Gurbel, P.A., Bliden, K.P., Hiatt, B.L. and O’Connor, C.M. (2003) Clopidogrel for coronary stenting: Response variability, drug resistance, and the effect of pretreatment platelet reactivity. Circulation, 107, 2908-2913. doi:10.1161/01.CIR.0000072771.11429.83
[8] Angiolillo, D.J., Fernandez-Ortiz, A., Alfonso, F., Bernardo, E.B., Macaya, C., Bass, T.A. and Costa, M.A. (2007) Variability in individual responsiveness to clopidogrel. Clinical implications, management, and future prospectives. Journal of Am. Collage of Cardiology, 49, 1505-1516. doi:10.1016/j.jacc.2006.11.044
[9] Taubert, D., Kastrati, A., Harlfinger, S., Gorchakova, O., Lazar, A., von Beckerath, N., Schmig, A. and Schomig, E. (2004) Pharmacokinetics of clopidogrel after administration of a high loading dose. Thrombosis and Haemostasis, 92, 311-316.
[10] FDA Drug Safety Communication (2010) Reduced effectiveness of plavix (clopidogrel) in patients who are poor metabolizers of the drug. http://www.fda.gov
[11] Bailey, L.A., Sistino, J.J. and Uber, W.E. (2005) Is platelet function as measured by Thrombelastograph monitoring in whole blood affected by platelet inhibitors? Journal of Extra Corporeal Technology, 37, 43-47.
[12] Khan, H., Belsher, J., Yilmaz, M., Afessa, B., Winters, J.L., Moore, S.B., Hubmayr, R.D. and Cajic, O. (2007) Fresh-frozen plasma and platelet transfusions are associated with development of acute lung injury in critically ill medical patients. Chest, 131, 1308-1314. doi:10.1378/chest.06-3048
[13] Pereboom, I.T., de Boer, M.T., Haagsma, E.B., Hendriks, G.D., Lisman, T. and Porte, R.J. (2009) Platelet transfusion during liver transplantation is associated with increased postoperative mortality due to acute lung injury. Anesthesia & Analgesia, 108, 1083-1091. doi:10.1213/ane.0b013e3181948a59
[14] Spieker, H., Benckert, C., Quante, M., Thelen, A., Gaebelein, G., Kaisers, U. and Jonas, S. (2012) Successful liver transplantation with continued dual antiplatelet therapy. Annals of Transplantation, 17, 127-130. doi:10.12659/AOT.883231

  
comments powered by Disqus

Copyright © 2019 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.